Home › NDC Lookup › RxCUI directory › RxCUI 2706325

Thyroid (USP) 75 MG Oral Tablet — RxCUI 2706325

RxNorm drug concept · Semantic clinical drug
RxCUI 2706325 Semantic clinical drug · SCD ● Current RxNorm concept 16 FDA products 31 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2706325
Official nameThyroid (USP) 75 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslevothyroxine sodium 47.5 MCG / liothyronine sodium 11.25 MCG Oral Tablet; thyroid 75 MG (1 1/4 grain) Oral Tablet
FDA products mapped16
Package NDCs mapped31
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Thyroid: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. Desiccated thyroid — the active ingredient in products like Amerithroid and Thyroid Tablets — is made from dried pig (porcine) thyroid glands. It naturally contains...
  • What exactly is desiccated thyroid, and is it different from the synthetic thyroid hormone my friend takes?
  • It does matter a bit. Fasting actually increases the absorption of thyroid hormones, so many people take their tablet first thing in the morning, about 30–60 minutes before eating....
  • Can I take my thyroid tablet with breakfast, or does it matter?
📖 Read our full Thyroid guide →

🕸️ Concept Web — How Thyroid (USP) 75 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Thyroid (USP) 75 MG Oral Tablet RxCUI 2706325

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Thyroid (USP) 10572
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Evexithroid 2725182
    • Renthyroid 2706310
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Thyroid (USP) Oral Tablet 374122
    • Thyroid (USP) Oral Product 1162082
    • Thyroid (USP) Pill 1162083
    • Thyroid (USP) Oral Tablet [Evexithroid] 2725186
    • Thyroid (USP) Oral Tablet [Renthyroid] 2706314
    • Evexithroid Oral Product 2725184
    • Evexithroid Pill 2725185
    • Renthyroid Oral Product 2706312
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Thyroid (USP) 75 MG SCDC · 2706324
  • Thyroid (USP) Oral Tablet SCDF · 374122
  • Thyroid (USP) Oral Product SCDG · 1162082
  • Thyroid (USP) Pill SCDG · 1162083

Brand-Name Concepts

  • Thyroid (USP) 75 MG Oral Tablet [Evexithroid] SBD · 2725199
  • Thyroid (USP) 75 MG Oral Tablet [Renthyroid] SBD · 2706327
  • Thyroid (USP) 75 MG [Evexithroid] SBDC · 2725198
  • Thyroid (USP) 75 MG [Renthyroid] SBDC · 2706326
  • Thyroid (USP) Oral Tablet [Evexithroid] SBDF · 2725186
  • Thyroid (USP) Oral Tablet [Renthyroid] SBDF · 2706314
  • Evexithroid Oral Product SBDG · 2725184
  • Evexithroid Pill SBDG · 2725185
  • Renthyroid Oral Product SBDG · 2706312
  • Renthyroid Pill SBDG · 2706313

📦 FDA Products & Package NDCs

16 products · 31 package NDCs
31 package NDCs map to RxCUI 2706325 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
64950-0170-01 100 TABLET in 1 BOTTLE (64950-170-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0170-09 90 TABLET in 1 BOTTLE (64950-170-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0170-14 14 TABLET in 1 BOTTLE (64950-170-14) RenThyroid Genus Lifesciences 2025-03-01
64950-0171-01 100 TABLET in 1 BOTTLE (64950-171-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0171-09 90 TABLET in 1 BOTTLE (64950-171-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0171-14 14 TABLET in 1 BOTTLE (64950-171-14) RenThyroid Genus Lifesciences 2025-03-01
64950-0172-01 100 TABLET in 1 BOTTLE (64950-172-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0172-09 90 TABLET in 1 BOTTLE (64950-172-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0172-14 14 TABLET in 1 BOTTLE (64950-172-14) RenThyroid Genus Lifesciences 2025-03-01
64950-0173-01 100 TABLET in 1 BOTTLE (64950-173-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0173-09 90 TABLET in 1 BOTTLE (64950-173-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0173-14 14 TABLET in 1 BOTTLE (64950-173-14) RenThyroid Genus Lifesciences 2025-03-01
64950-0174-01 100 TABLET in 1 BOTTLE (64950-174-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0174-09 90 TABLET in 1 BOTTLE (64950-174-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0174-14 14 TABLET in 1 BOTTLE (64950-174-14) RenThyroid Genus Lifesciences 2025-03-01
64950-0175-01 100 TABLET in 1 BOTTLE (64950-175-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0175-09 90 TABLET in 1 BOTTLE (64950-175-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0179-01 100 TABLET in 1 BOTTLE (64950-179-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0179-09 90 TABLET in 1 BOTTLE (64950-179-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0179-14 14 TABLET in 1 BOTTLE (64950-179-14) RenThyroid Genus Lifesciences 2025-03-01
64950-0180-01 100 TABLET in 1 BOTTLE (64950-180-01) RenThyroid Genus Lifesciences 2025-03-01
64950-0180-09 90 TABLET in 1 BOTTLE (64950-180-09) RenThyroid Genus Lifesciences 2025-03-01
64950-0180-14 14 TABLET in 1 BOTTLE (64950-180-14) RenThyroid Genus Lifesciences 2025-03-01
73352-0693-10 100 TABLET in 1 BOTTLE (73352-693-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0694-10 100 TABLET in 1 BOTTLE (73352-694-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0695-10 100 TABLET in 1 BOTTLE (73352-695-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0696-10 100 TABLET in 1 BOTTLE (73352-696-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0697-10 100 TABLET in 1 BOTTLE (73352-697-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0698-10 100 TABLET in 1 BOTTLE (73352-698-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0699-10 100 TABLET in 1 BOTTLE (73352-699-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
73352-0700-10 100 TABLET in 1 BOTTLE (73352-700-10) EvexiTHROID Trifluent Pharma, LLC 2025-10-12
Observed labelers: Genus Lifesciences (23) · Trifluent Pharma, LLC (8) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.